HIV reservoirs are groups of immune system cells that contain HIV genetic material, allowing the virus to persist even when antiretroviral treatment controls viral replication. These reservoirs primarily develop in certain CD4 T cells and other immune cells. Understanding how they form, remain inactive, and respond to treatment is important for HIV research. Scientists continue investigating the biological mechanisms.
HIV reservoirs represent one of the major challenges in developing a complete cure for HIV. Understanding their formation, location, biological activity, and interaction with treatment helps researchers investigate why the virus can persist for many years.
HIV reservoirs develop when the virus enters susceptible immune cells and integrates its genetic material into the DNA of the host cell. This process allows HIV to remain inside the cell, sometimes in an inactive state known as latency.
CD4 T lymphocytes are among the primary cells involved in HIV reservoir formation. These cells coordinate immune responses and help the body fight infections. When HIV infects a CD4 T cell, viral genetic material can become permanently integrated into the cell's DNA.
Some infected cells continue producing new viruses, while others become latently infected. During latency, the viral genetic material remains present without actively producing significant amounts of new virus. Because these cells are not actively producing HIV, they can escape many immune detection mechanisms and remain unaffected by standard antiretroviral treatment.
Important characteristics of HIV reservoir development include:
Viral integration: HIV inserts its genetic material into the DNA of infected immune cells.
Cellular latency: Some infected cells carry inactive HIV genetic material.
Long-term persistence: Reservoir cells can survive for extended periods.
Cell division: Infected cells may multiply, producing additional cells containing HIV genetic material.
Immune evasion: Latently infected cells may remain difficult for the immune system to recognize.
These processes contribute to the persistence of HIV even when treatment successfully suppresses viral replication.
HIV reservoirs are not restricted to one specific location. They can exist in different tissues and immune cell populations throughout the body. Although resting memory CD4 T cells are considered a major reservoir, researchers have also identified other cell types and anatomical locations that may contribute to viral persistence.
The lymph nodes, gastrointestinal tract, and other lymphoid tissues are important areas where HIV-infected cells can be found. These tissues contain immune cells that support immune responses and provide environments where HIV can persist.
Researchers also investigate the possible contribution of macrophages and other immune cells to HIV persistence. Their role may differ depending on the tissue environment, infection stage, and biological characteristics of the infected cells.
Some important reservoir locations and characteristics include:
Memory CD4 T cells: Long-lived immune cells that can carry integrated HIV DNA.
Lymph nodes: Immune tissues where infected cells may remain and interact with other immune cells.
Gut-associated lymphoid tissue: Contains substantial populations of immune cells that can be affected by HIV.
Macrophages: Immune cells being studied for their potential contribution to persistent HIV infection.
Central nervous system: Certain immune-related cells may contain HIV genetic material in this protected anatomical environment.
Understanding these different reservoirs helps researchers investigate viral persistence beyond the bloodstream. Blood tests alone cannot identify every infected cell or measure the complete size of the body's HIV reservoir.
Researchers continue studying how viral latency, immune cell survival, tissue environments, and cellular activity influence HIV persistence. This knowledge supports investigations into new approaches for achieving sustained HIV remission and developing potential curative strategies.